Impact of in Vivo Glycation of LDL on Platelet Aggregation and Monocyte Chemotaxis in Diabetic Psammomys obesus

Lipids

Volumn 39, Issue 1, 2004, Pages 81-85

  Zoltowska, Monika ^a,b   Delvin, Edgard ^a,b   Ziv, Ehud ^c   Peretti, Noel ^a,b   Chartré, Manon ^a,b   Levy, Emile ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; CARDIOVASCULAR SYSTEM; CHOLESTEROL; DISEASES; ESTERS; INSULIN; NUTRITION;

DIABETES; INSULIN RESISTANCE; OBESITY;

LIPIDS;

ADENOSINE DIPHOSPHATE; CARBON 14; CHOLESTEROL; CHOLESTEROL ESTER; COLLAGEN; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN; OLEIC ACID; THROMBIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CHEMOTAXIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET; ESTERIFICATION; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; GLYCATION; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PSAMMOMYS OBESUS; RAT; STATISTICAL ANALYSIS; THROMBOCYTE AGGREGATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GERBILLINAE; GLYCOSYLATION; LIPOPROTEINS, LDL; MONOCYTES; PLATELET AGGREGATION;

ANIMALIA; PSAMMOMYS; PSAMMOMYS OBESUS;

EID: 1542333783     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-004-1205-7     Document Type: Article

References (34)

1. Timar-Banu, O., Beauregard, H., Tousignant, J., Lassonde, M., Harris, P., Viau, G., Vachon, L., Levy, E., and Abribat, T. (2001) Development of Noninvasive and Quantitative Methodologies for the Assessment of Chronic Ulcers and Scars in Humans, Wound Repair Regen. 9, 123-132.
2. Knopp, R.H., Retzlaff, B., Aikawa, K., and Kahn, S.E. (2003) Management of Patients with Diabetic Hyperlipidemia. Am. J. Cardiol. 91, 24E-28E.
3. Sakaguchi, T., Yan, S.F., Yan, S.D., Belov, D., Rong, L.L., Sousa, M., Andrassy, M., Marso, S.P., Duda, S., Arnold, B., et al. (2003) Central Role of RAGE-Dependent Neointimal Expansion in Arterial Restenosis, J. Clin. Invest. III, 959-972.
4. Vlassara, H., and Palace, M.R. (2002) Diabetes and Advanced Glycation End Products, J. Intern. Med. 251, 87-101.
5. Schleicher, E., Deufel, T., and Wieland, O.H. (1981) Nonenzymatic Glycosylation of Human Serum Lipoproteins. Elevated Epsilon-Lysine Glycosylated Low Density Lipoprotein in Diabetic Patients, FEBS Lett. 129, 1-4.
6. Mironova, M.A., Klein, R.L., Virella, G.T., and Lopes-Virella, M.F. (2000) Anti-modified LDL Antibodies, LDL-Containing Immune Complexes, and Susceptibility of LDL to in vitro Oxidation in Patients with Type 2 Diabetes, Diabetes 49, 1033-1041.
7. Klein, R.L., Laimins, M., and Lopes-Virella, M.F. (1995) Isolation, Characterization, and Metabolism of the Glycated and Nonglycated Subfractions of Low-Density Lipoproteins Isolated from Type I Diabetic Patients and Nondiabetic Subjects, Diabetes 44, 1093-1098.
8. Wang, X., Bucala, R., and Milne, R. (1998) Epitopes Close to the Apolipoprotein B Low Density Lipoprotein Receptor-Binding Site Are Modified by Advanced Glycation End Products, Proc. Natl. Acad. Sci. USA 95, 7643-7647.
9. Zimmermann, R., Panzenbock, U., Wintersperger, A., Levak-Frank, S., Graier, W., Glatter, O., Fritz, G., Kostner, G.M., and Zechner, R. (2001) Lipoprotein Lipase Mediates the Uptake of Glycated LDL in Fibroblasts, Endothelial Cells, and Macrophages, Diabetes 50, 1643-1653.
10. Bucala, R., Makita, Z., Vega, G., Grundy, S., Koschinsky, T., Cerami, A., and Vlassara, H. (1994) Modification of Low Density Lipoprotein by Advanced Glycation End Products Contributes to the Dyslipidemia of Diabetes and Renal Insufficiency, Proc. Natl. Acad. Sci. USA 91, 9441-9445.
11. Lopes-Virella, M.F., Klein, R.L., Lyons, T.J., Stevenson, H.C., and Witztum, J.L. (1988) Glycosylation of Low-Density Lipoprotein Enhances Cholesteryl Ester Synthesis in Human Monocyte-Derived Macrophages, Diabetes 37, 550-557.
12. Bellomo, G., Maggi, E., Poli, M., Agosta, F.G., Bollati, P., and Finardi, G. (1995) Autoantibodies Against Oxidatively Modified Low-Density Lipoproteins in NIDDM, Diabetes 44, 60-66.
13. Witztum, J.L., Steinbrecher, U.P., Kesaniemi, Y.A., and Fisher, M. (1984) Autoantibodies to Glucosylated Proteins in the Plasma of Patients with Diabetes Mellitus, Proc. Natl. Acad. Sci. USA 81, 3204-3208.
14. Kalderon, B., Adler, J.H., Levy, E., and Gutman, A. (1983) Lipogenesis in the Sand Rat (Psammomys obesus), Am. J. Physiol. 244, E480-E486.
15. Zoltowska, M., St-Louis, J., Ziv, E., Sicotte, B., Delvin, E., and Levy, E. (2003) Vascular Responses to α-Adrenergic Stimulation and Depolarization Are Enhanced in Insulin Resistant and Diabetic Psammomys obesus, Can. J. Physiol. Pharmacol. 81, 704-710.
16. Zoltowska, M., Ziv, E., Delvin, E., Stan, S., Bar-On, H., Kalman, R., and Levy, E. (2001) Circulating Lipoproteins and Hepatic Sterol Metabolism in Psammomys obesus Prone to Obesity, Hyperglycemia and Hyperinsulinemia, Atherosclerosis 157, 85-96.
17. Suc, I., Brunet, S., Mitchell, G., Rivard, G.E., and Levy, E. (2003) Oxidative Tyrosylation of High Density Lipoproteins Impairs Cholesterol Efflux from Mouse J774 Macrophages: Role of Scavenger Receptors, Classes A and B, J. Cell Sci. 116, 89-99.
18. Levy, E., Thibault, L., Roy, C.C., Letarte, J., Lambert, M., and Seidman, E.G. (1990) Mechanisms of Hypercholesterolaemia in Glycogen Storage Disease Type I: Defective Metabolism of Low Density Lipoprotein in Cultured Skin Fibroblasts, Eur. J. Clin. Invest. 20, 253-260.
19. Lyons, T.J., Baynes, J.W., Patrick, J.S., Colwell, J.A., and Lopes-Virella, M.F. (1986) Glycosylation of Low Density Lipoprotein in Patients with Type 1 (insulin-dependent) Diabetes: Correlations with Other Parameters of Glycaemic Control, Diabetologia 29, 685-689.
20. Keren, P., George, J., Keren, G., and Harats, D. (2001) Non-Obese Diabetic (NOD) Mice Exhibit an Increased Cellular Immune Response to Glycated-LDL but Are Resistant to High Fat Diet Induced Atherosclerosis, Atherosclerosis 157, 285-292.
21. Watanabe, J., Wohltmann, H.J., Klein, R.L., Colwell, J.A., and Lopes-Virella, M.F. (1988) Enhancement of Platelet Aggregation by Low-Density Lipoproteins from IDDM Patients, Diabetes 37, 1652-1657.
22. Quinn, M.T., Parthasarathy, S., Fong, L.G., and Steinberg, D. (1987) Oxidatively Modified Low Density Lipoproteins: A Potential Role in Recruitment and Retention of Monocyte/Macrophages During Atherogenesis, Proc. Natl. Acad. Sci. USA 84, 2995-2998.
23. Marcil, V., Delvin, E., Seidman, E., Poitras, L., Zoltowska, M., Garofalo, C., and Levy, E. (2002) Modulation of Lipid Synthesis, Apolipoprotein Biogenesis, and Lipoprotein Assembly by Butyrate, Am. J. Physiol. Gastrointest. Liver Physiol. 283, G340-G346.
24. Stitt, A.W., Jenkins, A.J., and Cooper, M.E. (2002) Advanced Glycation End Products and Diabetic Complications, Expert. Opin. Investig. Drugs. 11, 1205-1223.
25. Bucala, R., Model, P., and Cerami, A. (1984) Modification of DNA by Reducing Sugars: A Possible Mechanism for Nucleic Acid Aging and Age-Related Dysfunction in Gene Expression, Proc. Natl. Acad. Sci. USA 81, 105-109.
26. Howard, E.W., Benton, R., Ahern-Moore, J., and Tomasek, J.J. (1996) Cellular Contraction of Collagen Lattices Is Inhibited by Nonenzymatic Glycation, Exp. Cell. Res. 228, 132-137.
27. Paget, C., Lecomte, M., Ruggiero, D., Wiernsperger, N., and Lagarde, M. (1998) Modification of Enzymatic Antioxidants in Retinal Microvascular Cells by Glucose or Advanced Glycation End Products, Free Radic. Biol. Med. 25, 121-129.
28. Giardino, I., Edelstein, D., and Brownlee, M. (1994) Nonenzymatic Glycosylation in vitro and in Bovine Endothelial Cells Alters Basic Fibroblast Growth Factor Activity. A Model for Intracellular Glycosylation in Diabetes, J. Clin. Invest. 94, 110-117.
29. Stitt, A.W., Li, Y.M., Gardiner, T.A., Bucala, R., Archer, D.B., and Vlassara, H. (1997) Advanced Glycation End Products (AGEs) Co-localize with AGE Receptors in the Retinal Vasculature of Diabetic and of AGE-Infused Rats, Am. J. Pathol. 150, 523-531.
30. Stitt, A.W., He, C., Friedman, S., Scher, L., Rossi, P., Ong, L., Founds, H., Li, Y.M., Bucala, R., and Vlassara, H. (1997) Elevated AGE-Modified ApoB in Sera of Euglycemic, Normolipidemic Patients with Atherosclerosis: Relationship to Tissue AGEs, Mol. Med. 3, 617-627.
31. Hoff, H.F., Whitaker, T.E., and O'Neil, J. (1992) Oxidation of Low Density Lipoprotein Leads to Particle Aggregation and Altered Macrophage Recognition, J. Biol. Chem. 267, 602-609.
32. The Diabetes Control and Complications Trial Research Group (1993) The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus, N. Engl. J. Med. 329, 977-986.
33. Ferretti, G., Rabini, R.A., Bacchetti, T., Vignini, A., Salvolini, E., Ravaglia, F., Curatola, G., and Mazzanti, L. (2002) Glycated Low Density Lipoproteins Modify Platelet Properties: A Compositional and Functional Study, J. Clin. Endocrinol. Metab. 87, 2180-2184.
34. Curtiss, L.K., and Witztum, J.L. (1983) A Novel Method for Generating Region-Specific Monoclonal Antibodies to Modified Proteins. Application to the Identification of Human Glucosylated Low Density Lipoproteins, J. Clin. Invest. 72, 1427-1438.